BACKGROUND: Hepatitis C virus (HCV) is a leading cause of hepatocellular carcinoma and cirrhosis in the United States and is known to be transmitted via pathways associated with substance use (e.g., injection drug use and intranasal drug use). OBJECTIVE: Although individuals with serious mental illness (SMI) have a high prevalence of HCV, the nature of this relationship is unclear and is the subject of this investigation. METHOD: The authors determined unadjusted and adjusted recorded prevalence of HCV among a national sample of veterans with and without SMI. RESULTS: HCV was recorded in 8.1% of patients with bipolar disorder, 7.1% of patients with schizophrenia, and 2.5% of patients without SMI. Substance use increased HCV risk among SMI patients; patients with bipolar disorder had greater risk than patients with schizophrenia. CONCLUSION: Efforts to address HCV among patients with serious mental illness and co-occurring substance abuse are warranted.
BACKGROUND:Hepatitis C virus (HCV) is a leading cause of hepatocellular carcinoma and cirrhosis in the United States and is known to be transmitted via pathways associated with substance use (e.g., injection drug use and intranasal drug use). OBJECTIVE: Although individuals with serious mental illness (SMI) have a high prevalence of HCV, the nature of this relationship is unclear and is the subject of this investigation. METHOD: The authors determined unadjusted and adjusted recorded prevalence of HCV among a national sample of veterans with and without SMI. RESULTS:HCV was recorded in 8.1% of patients with bipolar disorder, 7.1% of patients with schizophrenia, and 2.5% of patients without SMI. Substance use increased HCV risk among SMIpatients; patients with bipolar disorder had greater risk than patients with schizophrenia. CONCLUSION: Efforts to address HCV among patients with serious mental illness and co-occurring substance abuse are warranted.
Authors: Herbert C Szeto; Robert K Coleman; Parisa Gholami; Brian B Hoffman; Mary K Goldstein Journal: Am J Manag Care Date: 2002-01 Impact factor: 2.229
Authors: Fred C Osher; Richard W Goldberg; Scot W McNary; Marvin S Swartz; Susan M Essock; Marian I Butterfield; Stanley D Rosenberg Journal: Psychiatr Serv Date: 2003-06 Impact factor: 3.084
Authors: Stanley Rosenberg; Mary Brunette; Thomas Oxman; Bryan Marsh; Allen Dietrich; Kim Mueser; Robert Drake; Will Torrey; Robert Vidaver Journal: Psychiatr Serv Date: 2004-06 Impact factor: 3.084
Authors: W Dean Klinkenberg; Robert J Caslyn; Gary A Morse; Robert D Yonker; Suzanne McCudden; Fassil Ketema; Niel T Constantine Journal: Compr Psychiatry Date: 2003 Jul-Aug Impact factor: 3.735
Authors: Evan Trager; Mandana Khalili; Carmen L Masson; Eric Vittinghoff; Jennifer Creasman; Christina Mangurian Journal: Am J Public Health Date: 2016-02-18 Impact factor: 9.308
Authors: Seth Himelhoch; Richard Goldberg; Christine Calmes; Deborah Medoff; Eric Slade; Lisa Dixon; Gerard Gallucci; Stanley Rosenberg Journal: J Community Psychol Date: 2011-02-02
Authors: W N Southern; M-L Drainoni; B D Smith; C L Christiansen; D McKee; A L Gifford; C M Weinbaum; D Thompson; E Koppelman; S Maher; A H Litwin Journal: J Viral Hepat Date: 2010-05-20 Impact factor: 3.728
Authors: Michael B Blank; Seth S Himelhoch; Alexandra B Balaji; David S Metzger; Lisa B Dixon; Charles E Rose; Emeka Oraka; Annet Davis-Vogel; William W Thompson; James D Heffelfinger Journal: Am J Public Health Date: 2014-02-13 Impact factor: 9.308
Authors: William N Southern; Mari-Lynn Drainoni; Bryce D Smith; Elisa Koppelman; M Diane McKee; Cindy L Christiansen; Allen L Gifford; Cindy M Weinbaum; Alain H Litwin Journal: Qual Manag Health Care Date: 2014 Jan-Mar Impact factor: 0.926